appengine.ai

Artificial Intelligence | Machine Learning | Machine Perception Ultromics | AI Enabled Cardiovascular Imaging Solutions


Consumer, Machine Learning, Healthcare, Cardiovascular Diagnosis, Diagnostic Tools, Digital Health Records Oxford, Oxfordshire, United Kingdom

Ultromics

Artificial Intelligence | Machine Learning | Machine Perception


Ultromics | AI Enabled Cardiovascular Imaging Solutions

Ultromics

Machine Learning, Healthcare, Cardiovascular Diagnosis, Diagnostic Tools, Digital Health Records


Oxford, Oxfordshire, United Kingdom

Ultromics is setting new standards for world-class cardiovascular diagnostic tools, together with clinicians and powered by artificial intelligence.

They are building world-class diagnostic aids to help cardiologists — powered by artificial intelligence. To date, they have developed the world’s most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.

 

B2B

26 to 50

Series A

$26,024,354

Scaling Up

2017

 
 

Managed Health Care
Health Care Facilities & Hospitals

N/A

N/A

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing


Terraform

Terraform

SaMD

SaMD


Image

Image

Video

Video

Audio

Audio

Semi-Structured

Semi-Structured

 

   Software


IaaS

IaaS

Javascript

Javascript

Typescript

Typescript

Python

Python

R

R


NA

NA

 
 

Sep 2020

  • Ultromics Awarded NHSX Grant to Implement EchoGo in The NHS

May 2020

  • Mayo Clinic Collaborates with Ultromics to Optimize The Impact of AI Tools On Care Pathways
 
 

View All

Clinical Applications Lead/Ultrasound AI

Remote, Remote

Echocardiographer

Remote, Remote

Software Test Engineer

Oxford , England

Statistician

Oxford , England

Customer Experience Manager - IT

Oxford , England

 
 

4

1

$33 M

Company was founded 2017 and it took almost 4 years (Aug 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

08/17/2021

Series B

$33 M

Blue Venture Fund, Optum Ventures, GV, Oxford Sciences Innovation

Date : 08/17/2021

Round: Series B

$ Raised: $33 M

Investors: Blue Venture Fund, Optum Ventures, GV, Oxford Sciences Innovation

 
 
Amir Hasan


Amir Hasan
CCO

Ross Upton


Ross Upton
Founder & CEO

Gary Woodward


Gary Woodward
CTO